Multi-Stage Biodegradable Drug Delivery Platform
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 61/799,194, filed Mar 15, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,130,760 | Multi-Stage Biodegradable Drug Delivery Platform In force · Medium confidence | Incube Labs, LLC | In force | Medium confidence | ||
| US 11,944,780 | Multi-Stage Biodegradable Drug Delivery Platform In force · Medium confidence | Incube Labs, LLC | In force | Medium confidence | ||
| US 10,507,282 | Multi-Stage Biodegradable Drug Delivery Platform Lapsed Dec 17, 2023 on the fee record Ended Dec 17, 2023 · Medium confidence | Incube Labs, LLC | Lapsed Dec 17, 2023 on the fee record | Ended Dec 17, 2023 | Medium confidence | |
| Application 18/584,621 | Multi-Stage Biodegradable Drug Delivery Platform Pending Not granted | Incube Labs, LLC | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Incube Labs, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.